Follow
Kien Nham
Kien Nham
Unknown affiliation
Verified email at medicalcityhealth.com
Title
Cited by
Cited by
Year
PD-L1 on host cells is essential for PD-L1 blockage-mediated tumor regression
H Tang, Y Liang, RA Anders, JM Taube, X Qui, A Mulgaonkar, X Liu, ...
The Journal of Clinical Investigation, 2018
4822018
An Adipose Tissue Atlas: An Image-Guided Identification of Human-like BAT and Beige Depots in Rodents
OKO Fang Zhang, Guiyang Hao, Mengle Shao, Kien Nham, Yu An, Qiong Wang, Yi ...
Cell Metabolism 27 (1), 252-262, 2018
2182018
The hexosamine biosynthesis pathway is a targetable liability in KRAS/LKB1 mutant lung cancer
J Kim, HM Lee, F Cai, B Ko, C Yang, EL Lieu, N Muhammad, S Rhyne, ...
Nature metabolism 2 (12), 1401-1412, 2020
872020
PD-L1 detection using 89Zr-atezolizumab immuno-PET in renal cell carcinoma tumorgrafts from a patient with favorable nivolumab response
J Vento, A Mulgaonkar, L Woolford, K Nham, A Christie, A Bagrodia, ...
Journal for immunotherapy of cancer 7, 1-6, 2019
592019
PET imaging of occult tumours by temporal integration of tumour-acidosis signals from pH-sensitive 64Cu-labelled polymers
G Huang, T Zhao, C Wang, K Nham, Y Xiong, X Gao, Y Wang, G Hao, ...
Nature biomedical engineering 4 (3), 314-324, 2020
462020
Tumor uptake of triazine dendrimers decorated with four, sixteen, and sixty-four PSMA-targeted ligands: Passive versus active tumor targeting
J Lim, B Guan, K Nham, G Hao, X Sun, EE Simanek
Biomolecules 9 (9), 421, 2019
172019
ImmunoPET Imaging with 89Zr-Labeled Atezolizumab Enables In Vivo Evaluation of PD-L1 in Tumorgraft Models of Renal Cell Carcinoma
A Mulgaonkar, R Elias, L Woolford, B Guan, K Nham, P Kapur, A Christie, ...
Clinical Cancer Research 28 (22), 4907-4916, 2022
92022
Breast tumor micro-calcification induced by bone morphogenetic protein-2: a new murine model for human breast tumor diagnosis
A Hajibeigi, K Nasr, D Udayakumar, K Nham, RE Lenkinski
Contrast Media & Molecular Imaging, 2018
52018
Selective depletion of radiolabeled HER2-specific antibody for contrast improvement during PET
P Khare, W Sun, S Ramakrishnan, R Swiercz, G Hao, ST Lo, K Nham, ...
MAbs 13 (1), 1976705, 2021
22021
Functional imaging of RAS pathway targeting in malignant peripheral nerve sheath tumor cells and xenografts
E Butler, B Schwettmann, S Geboers, G Hao, J Kim, K Nham, X Sun, ...
Pediatric Blood & Cancer 67 (12), e28639, 2020
22020
The hexosamine biosynthesis pathway is a targetable liability in lung cancers with concurrent KRAS and LKB1 mutations
J Kim, F Cai, B Ko, C Yang, HM Lee, N Muhammad, K Li, M Haloul, W Gu, ...
bioRxiv, 2020.04. 13.039669, 2020
12020
Design and Synthesis of a Novel Class of Theranostic Small-Molecule Drug Conjugates for Targeted Drug Delivery and Controlled Release
S Debnath, G Hao, D Shryock, K Nham, H Hammers, X Sun
Journal of Nuclear Medicine 60 (supplement 1), 1622-1622, 2019
12019
Chemically Identical Pair of Theranostic Small-Molecule Drug Conjugates for Prostate Cancer Imaging and Chemotherapy
G Hao, B Guan, Y Wu, S Debnath, J Yang, Y Xiong, L Yang, K Nham, ...
Nuclear Medicine and Biology 126, 108791, 2023
2023
PD-L1 PET: A potential biomarker of checkpoint inhibitor sensitivity in renal cancer
A Mulgaonkar, L Woolford, R Elias, K Nham, B Guan, G Hao, C Stevens, ...
Cancer Research 82 (12_Supplement), 1234-1234, 2022
2022
Immuno-PET Evaluation of In Vivo Therapeutic Resistance in Renal Cell Carcinoma Patient-Derived Xenografts
S Manna, A Mulgaonkar, L Woolford, K Nham, G Hao, LM Pop, I Bowman, ...
International Journal of Radiation Oncology, Biology, Physics 105 (1), E665, 2019
2019
Immuno-PET imaging with 89Zr-atezolizumab in low and high PD-L1 expressing renal cell carcinoma patient-derived xenograft models
G Hao, A Mulgaonkar, L Woolford, K Nham, B Guan, J Brugarolas, X Sun
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS 62, S236-S237, 2019
2019
Elevated PD-L1 Expression was Observed in Renal Cell Carcinoma by Immuno-PET after Stereotactic Ablative Body Radiation Treatment
A Mulgaonkar, L Woolford, S Manna, K Nham, G Hao, R Hannan, ...
Journal of Nuclear Medicine 60 (supplement 1), 1023-1023, 2019
2019
Noninvasive Differentiation of Glioblastoma Multiforme (GBM) EGFR-Variants Using PET Imaging with 11C-Glutamine
ST Lo, G Gao, K Nasr, K Nham, N Rydberg, A Habib, X Sun
Journal of Nuclear Medicine 60 (supplement 1), 207-207, 2019
2019
A practical workflow for statistical parametric mapping analysis of tau imaging in mice
K Nham, J Yang, K Nsar, TL Thomas, J Vaquer-Alicea, MI Diamond, ...
World Molecular Imaging Congress, 2018
2018
Automated production of [1-11C] palmitate using commercial synthesizers
G Hao, N Rydberg, R Hallgren, K Nham, X Sun
Journal of Nuclear Medicine 59 (supplement 1), 1040-1040, 2018
2018
The system can't perform the operation now. Try again later.
Articles 1–20